Literature DB >> 10726893

Effects of Dai-kenchu-to on levels of 5-hydroxytryptamine (serotonin) and vasoactive intestinal peptides in human plasma.

T Nagano1, H Itoh, M Takeyama.   

Abstract

We examined the effects of Dai-kenchu-to (DKCT) on the levels of vasoactive intestinal peptide (VIP) and 5-hydroxytryptamine (serotonin; 5-HT) in plasma taken from 6 healthy subjects. A single oral administration of 7.5 g DKCT caused significant increases in plasma VIP at 30, 60 to 90 and 120 min (3.5-5.5 pg/ml), compared with the response in a placebo group (about 1.0 pg/ml). DKCT also caused significant increases in plasma 5-HT at 30 (121.8+/-7.3 ng/ml) and 60 (156.5+/-8.0 ng/ml) min, compared with the response in the placebo group (about 101 ng/ml). These results indicate that the stimulatory effect of DKCT on VIP-immunoreactive substance (VIP-IS) secretion is due, at least in part, to increased 5-HT levels in the abdomen. As a consequence, increased VIP-IS may improve feelings of coldness in the abdomen.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10726893     DOI: 10.1248/bpb.23.352

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  9 in total

Review 1.  Japanese herbal medicine in functional gastrointestinal disorders.

Authors:  H Suzuki; J M Inadomi; T Hibi
Journal:  Neurogastroenterol Motil       Date:  2009-03-25       Impact factor: 3.598

2.  The effect of traditional Japanese medicine (Kampo) on gastrointestinal function.

Authors:  Erito Mochiki; Mitsuhiro Yanai; Tetsuro Ohno; Hiroyuki Kuwano
Journal:  Surg Today       Date:  2010-11-26       Impact factor: 2.549

3.  Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001).

Authors:  Mitsuo Shimada; Yuji Morine; Hiroaki Nagano; Etsuro Hatano; Takashi Kaiho; Masaru Miyazaki; Toru Kono; Toshiya Kamiyama; Satoshi Morita; Junichi Sakamoto; Mitsuo Kusano; Shigetoyo Saji; Takashi Kanematsu; Masaki Kitajima
Journal:  Int J Clin Oncol       Date:  2014-03-06       Impact factor: 3.402

4.  Effect of the Japanese herbal kampo medicine dai-kenchu-to on postoperative adhesive small bowel obstruction requiring long-tube decompression: a propensity score analysis.

Authors:  Hideo Yasunaga; Hiroaki Miyata; Hiromasa Horiguchi; Kazuaki Kuwabara; Hideki Hashimoto; Shinya Matsuda
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-31       Impact factor: 2.629

5.  Clinical efficacy of Daikenchuto for gastrointestinal dysfunction following colon surgery: a randomized, double-blind, multicenter, placebo-controlled study (JFMC39-0902).

Authors:  Hidetoshi Katsuno; Koutarou Maeda; Takashi Kaiho; Katsuyuki Kunieda; Kimihiko Funahashi; Junichi Sakamoto; Toru Kono; Hirotoshi Hasegawa; Yoshiyuki Furukawa; Yoshihiro Imazu; Satoshi Morita; Masahiko Watanabe
Journal:  Jpn J Clin Oncol       Date:  2015-05-12       Impact factor: 3.019

6.  Efficacy and Safety of the Japanese Herbal Medicine Daikenchuto (DKT) in Elderly Fecal Incontinence Patients: A Prospective Study.

Authors:  Kazufumi Shimazutsu; Yusuke Watadani; Hiroki Ohge
Journal:  J Anus Rectum Colon       Date:  2022-01-28

Review 7.  Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application.

Authors:  Kazunari Tominaga; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2013-03-16       Impact factor: 7.527

8.  Ginseng in traditional herbal prescriptions.

Authors:  Ho Jae Park; Dong Hyun Kim; Se Jin Park; Jong Min Kim; Jong Hoon Ryu
Journal:  J Ginseng Res       Date:  2012-07       Impact factor: 6.060

9.  Traditional Japanese medicine daikenchuto improves functional constipation in poststroke patients.

Authors:  Takehiro Numata; Shin Takayama; Muneshige Tobita; Shuichi Ishida; Dai Katayose; Mitsutoshi Shinkawa; Takashi Oikawa; Takanori Aonuma; Soichiro Kaneko; Junichi Tanaka; Seiki Kanemura; Koh Iwasaki; Tadashi Ishii; Nobuo Yaegashi
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-25       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.